Search clinical trials for: Alemtuzumab s.c.
Total 1636 results
-
German CLL Study GroupCompletedChronic Lymphocytic LeukemiaGermany
-
M.D. Anderson Cancer CenterLeudositeTerminatedLymphoma, B-Cell | Lymphoma, T-Cell | Lymphoma, Low-Grade | Leukemia, Lymphocytic, Acute | Leukemia, Lymphocytic, ChronicUnited States
-
Novartis PharmaceuticalsRecruitingLupus NephritisChina, United States, Spain, Germany, Korea, Republic of, Italy, Thailand, Hungary, Argentina, Brazil, Singapore, Taiwan, France, Vietnam, Malaysia, Lithuania, Canada, India, Colombia, Romania, United Kingdom, Czechia, Guatemala, Mexico, Eston... and more
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI); Genzyme, a Sanofi CompanyCompleted
-
Genzyme, a Sanofi CompanyTerminatedNon-Hodgkins LymphomaUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnLymphomaUnited States, Australia, United Kingdom, Canada, France
-
Karolinska University HospitalSchering Nordiska ABCompleted
-
Latin American Cooperative Onco-Haematology Group...UnknownMycosis Fungoides | Sezary SyndromePeru
-
Genzyme, a Sanofi CompanyTerminatedHematologic MalignanciesUnited States
-
University Hospital MuensterUnknown
-
University of AlbertaJuvenile Diabetes Research FoundationCompleted
-
AstraZenecaRecruitingChronic Kidney Disease | HyperkalaemiaSpain, United Kingdom, Belgium, Italy, Netherlands, France, Germany
-
Ontario Clinical Oncology Group (OCOG)Sunnybrook Health Sciences Centre; Genzyme, a Sanofi CompanyCompletedAlemtuzumab and CHOP Chemotherapy for Aggressive Histological Peripheral T-Cell Lymphomas (ACCAPELA)Peripheral T-cell LymphomasCanada
-
Genzyme, a Sanofi CompanyTerminatedChronic Lymphocytic LeukemiaMacedonia, The Former Yugoslav Republic of, Bosnia and Herzegovina, Israel
-
Chronic Lymphocytic Leukemia Research ConsortiumBayerUnknownB-Cell Chronic Lymphocytic LeukemiaUnited States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Leiden University Medical CenterRecruitingSickle Cell DiseaseNetherlands
-
Genzyme, a Sanofi CompanyCompletedRelapsing Remitting Multiple SclerosisUnited States, Argentina, Australia, Belgium, Brazil, Canada, Czechia, Denmark, Germany, Israel, Italy, Mexico, Netherlands, Poland, Russian Federation, Spain, Sweden, Ukraine, United Kingdom
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingNetherlands, Spain, Germany, Israel, United Kingdom, Canada, Australia, United States, Italy, Argentina, Croatia, Russian Federation, Poland, Czechia, Belgium, France, Brazil, Austria, Denmark, Mexico, Serbia, Sweden, Ukraine
-
Samuel Forrester Hunter, MD, PhDUnknownMultiple SclerosisUnited States
-
Weill Medical College of Cornell UniversityBayerCompletedT-Cell Lymphoma | Lymphoma, Non-Hodgkin'sUnited States
-
Genzyme, a Sanofi CompanyCompletedB Cell Chronic Lymphocytic LeukemiaUnited States
-
German CLL Study GroupCompleted
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedMyelodysplastic SyndromesUnited States
-
Dana-Farber Cancer InstituteBayer; Genzyme, a Sanofi CompanyCompleted
-
Genzyme, a Sanofi CompanyCompletedLeukemia, Lymphocytic, Chronic, B-CellJapan
-
St. Jude Children's Research HospitalCompletedSevere Combined ImmunodeficiencyUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedT-LGL Lymphoproliferative DisordersUnited States
-
Johns Hopkins UniversityGenzyme, a Sanofi CompanyWithdrawnChronic Inflammatory Demyelinating NeuropathyUnited States
-
National Institute of Neurological Disorders and...Completed
-
National Cancer Institute (NCI)CompletedPeripheral T-Cell Lymphoma (PTCL) | T-Cell Prolymphocytic Leukemia | Cutaneous T Cell Lymphoma (CTCL) | T-Cell Lymphoma Relapsed | Adult T-Cell Leukemia (ATL)United States
-
University of Wisconsin, MadisonWithdrawnNew Onset Type 1 Diabetes MellitusUnited States
-
Genzyme, a Sanofi CompanyTerminatedNon-Hodgkin's LymphomaUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedAcute Lymphocytic LeukemiaFrance
-
Leeds Cancer Centre at St. James's University HospitalCompleted
-
Genzyme, a Sanofi CompanyTerminatedMultiple SclerosisUnited States, Australia, Austria, Belgium, Canada, Denmark, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, United Kingdom
-
Northwestern UniversityGenzyme, a Sanofi Company; Millennium Pharmaceuticals, Inc.Completed
-
Genzyme, a Sanofi CompanyCompletedLeukemia, Lymphocytic, Chronic, B-CellUnited States
-
University Hospital TuebingenCompletedMalignant MelanomaGermany
-
Boehringer IngelheimCompleted
-
Goethe UniversityCompletedLymphoma, Lymphoblastic | Adult Acute Lymphocytic Leukemia T-cellGermany
-
University of AlbertaJuvenile Diabetes Research FoundationCompleted
-
Nantes University HospitalChugai Pharmaceutical; French Innovative Leukemia OrganisationCompleted
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Russian Federation, Poland, Croatia, United Kingdom
-
Leti Pharma GmbHCompletedAllergic Rhinitis/Rhinoconjunctivitis +-Intermittent Asthma | Sensitization Against Betula Alba (Birch) PollenGermany
-
M.D. Anderson Cancer CenterWithdrawnLymphoma | Hodgkin's Disease
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)TerminatedChronic Lymphocytic LeukemiaUnited States
-
Alloksys Life Sciences B.V.Aix ScientificsCompletedAcute Rheumatoid ArthritisUnited Kingdom
-
University Hospital MuensterGenzyme, a Sanofi CompanyCompletedMultiple Sclerosis, Relapsing-RemittingGermany
-
Mahidol UniversityBayerTerminatedPeripheral T-Cell LymphomaThailand
-
Phramongkutklao College of Medicine and HospitalBayerTerminated